Objectives: To describe the incidence and microbiological features of carbapenemase-producing Enterobacteriaceae (CPE) from colonized patients in a Spanish university hospital during a cluster-randomized study [the Resistance of Gram-Negative Organisms: Studying Intervention Strategies (R-GNOSIS) project] on isolation strategies for faecal ESBL carriers.
Introduction
The emergence and dissemination of carbapenemase-producing Enterobacteriaceae (CPE) have been described worldwide. Carbapenemase genes are often contained on mobile genetic elements that facilitate transfer among different Enterobacteriaceae species. Carbapenemase production is normally linked to successful MDR clones commonly associated with healthcarerelated infections and increased morbidity and mortality. 1, 2 Until 2009, CPE prevalence in Spain was relatively low and normally related to VIM-1 and KPC enzymes. [3] [4] [5] Recently, CPE prevalence significantly increased owing to the dissemination of successful Klebsiella pneumoniae clones harbouring bla OXA-48 , mainly linked to healthcare exposure and prolonged hospital stay. [6] [7] [8] V C The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Sporadic cases of NDM-1 carriers have been also described, frequently as imported cases. 9, 10 As a consequence, regional guidelines have been implemented and declaration of CPE to public health authorities is now mandatory in some Spanish regions. 11 The aim of our study was to assess the occurrence, microbiological features and changes in population structure over time of CPE recovered from colonized patients admitted to our hospital during the European Resistance of Gram-Negative Organisms: Studying Intervention Strategies (R-GNOSIS) project.
Materials and methods

Study design
The R-GNOSIS project, an EU-funded project (R-GNOSIS-FP7-HEALTH-F3-2011-282512), was a two-arm, cluster-randomized, controlled study of two infection control strategies with crossover design. The objective was to evaluate the additional effects of a contact isolation strategy on the incidence of nosocomial ESBL-producing Enterobacteriaceae acquisition among hospitalized patients in two surgical wards (SWs) (Urology and Neurosurgery) and two medical wards (MWs) (Gastroenterology and Pneumology). Screening to detect CPE carriers was also performed. Infection control measures (contact isolation and standard precautions) were implemented after detection of each new case of carbapenemase colonization. Rectal samples were obtained at admission (within the 3 first days), weekly (for patients staying 7 days) and at discharge (for patients staying 3 days). Patients' clinical records were reviewed (Ethics Committee approved the study, reference 251/13).
Surveillance cultures and screening for carbapenemase production
A total of 15556 rectal swabs from 8209 patients were collected (March 2014-March 2016). Swabs were seeded on ChromoID-ESBL and ChromoID-CARB/OXA-48 selective chromogenic agar plates (bioMérieux, Marcy-l'Étoile, France) and incubated at 37 C for 24 or 48 h. Bacterial identification was confirmed by MALDI-TOF MS (Bruker-Daltonics, Bremen, Germany). Carbapenemase and ESBL production were phenotypically detected. 7 
Antibiotic susceptibility
Broth microdilution (MicroScan, Beckman, CA, USA), except for meropenem and fosfomycin, which were determined using MIC gradient strips (Liofilchem MIC-Test Strip, Rosetodegli Abruzzi, Italy), was performed and interpreted according to EUCAST guidelines.
Characterization of antibiotic resistance genes
Carbapenemase (bla VIM , bla OXA , bla NDM and bla KPC ) and ESBL (bla TEM , bla SHV and bla CTX-M ) genes were characterized. 7 
Clonal relatedness and diversity analysis
The genetic relatedness among CPE isolates was determined by PFGE, and isolates from each different K. pneumoniae and Escherichia coli PFGE cluster were studied by MLST. Relatedness dendrograms were generated (BioNumerics version 3.0, Applied Maths NV, Sint-Martens-Latem, Belgium) and diversity was determined [Simpson diversity index (SDI) estimation]. 12 
Statistical analysis
Differences in accumulated incidence rates over time were assessed using Poisson regression (Stata Statistical Software, Release 11; StataCorp LP, College Station, TX, USA). Student's t-test and the Mann-Whitney test were used to analyse continuous variables (RStudio Team 2016 version 1.0.44, RStudio, Boston, MA, USA). A P value ,0.05 was considered statistically significant.
Results
CPE prevalence and patients' characteristics
A total of 198 non-duplicated CPE isolates were recovered from 162 patients. The accumulated incidence was 2% (95% CI " 1.7%-2.3%), remaining unchanged over time (P " 0.41) (incidence rate ratio " 1.01, 95% CI " 0.98-1.02) (Figure 1 ).
Patients colonized with CPE were mostly elderly (median 74 years, range 26-98) and 59.9% (97/162) male. Overall, length of stay (LOS) was 15.5 days (range 1-215) with differences between MWs (LOS " 12.5 days) and SWs (LOS " 25.5 days) (P , 0.01). In 43 patients (43/162, 26.5%), CPE colonization was observed at admission (43/8209, 0.5%). Overall, prior admission in the last year was registered in 98 cases (98/162, 60.5%), and previous CPE-positive cultures were only confirmed in 8 cases. Another 11 patients (11/162, 6.8%), all of them positive at admission, had chronic underlying diseases or were derived from other hospitals or healthcare centres. In 91 patients (91/162, 56.2%), admission cultures were negative, but they became positive during hospitalization (91/8209, 1.1%). For this subset of patients, LOS was 27 days (21 in MWs versus 43 in SWs, P , 0.05) and LOS from the admission date until the first positive CPE culture was 18 days (range 1-130) (14 in MWs versus 29 in SWs, P , 0.05). In 91 patients, a discharge sample was collected and carbapenemase detection was negative in only 10 cases (10/91, 11%).
CPEs were also recovered in clinical samples from 28 patients (28/162, 17.3%). Urine was the most frequently affected sample (n " 22), followed by bronchial aspirate (n " 3), blood (n " 3), surgical wound (n " 2), cerebrospinal fluid (n " 1) and prosthesis (n " 1). (19/198, 9 .6%) and SHV-28 (4/ 198, 2%) production was mainly related to VIM-1-K. pneumoniae (Table S1 ).
Bacterial isolates and carbapenemase characterization
Distribution by semesters of different species, carbapenemases and wards is shown in Figure S1 .
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Antibiotic susceptibility
Non-susceptibility to carbapenems was variable, with OXA-48 producers showing the lowest non-susceptibility rates. Overall, amikacin, tigecycline and colistin were the most active antibiotics. Only one OXA-48-K. pneumoniae was non-susceptible to colistin (Table S2) .
Clonal relatedness and diversity analysis
Overall, 91 of 106 K. pneumoniae isolates were clustered into 11 major PFGE-types (A-K) which corresponded to 8 different STs. A-ST11-OXA-48-clone (n " 43), B-ST54-VIM-1-clone (n " 17) and C-ST101-NDM-1-clone (n " 8) were the most prevalent. Unique PFGE profiles and STs were also identified ( Figure S2) . A-ST11-OXA-48-CTX-M-15 and B-ST54-VIM-1-SHV-12 clone acquisition occurred during hospitalization in 23 (23/43) and 13 (13/17) cases, respectively.
E. coli isolates (n " 38) also exhibited a polyclonal structure with 30 different PFGE types belonging to 26 STs ( Figure S3 ). Thirteen isolates were grouped into the clonal complex (CC) 10 (13/38, 34.2%) including OXA-48 (11/13) and VIM-1 (2/13) producers.
PFGE analysis demonstrated unrelated patterns in E. cloacae complex (n " 15), Klebsiella aerogenes (n " 6), C. freundii (n " 5) and Klebsiella oxytoca (n " 8) isolates, but the same profile in all Kluyvera spp. isolates.
Species diversity tended to decrease (SDI semester 1 " 0.75-SDI semester 4 " 0.43) over time ( Figure S4 ). E. coli showed the greatest clonal diversity (SDI E. coli " 0.97) followed by E. cloacae complex (SDI E. cloacae " 0.92) and K. pneumoniae (SDI K. pneumoniae " 0.80).
Although the A-ST11-OXA-48-CTX-M-15-K. pneumoniae clone was the most prevalent, a greater number of new K. pneumoniae clones (n " 15), particularly OXA-48 producers (9/15), was observed during the last two semesters, leaving a higher SDI K. pneumoniae during this time (Figure 2, left-hand panel) . Conversely, a downward trend was noted in the E. coli diversity coinciding with CC10-OXA-48-E. coli emergence. The same trend was observed analysing the OXA-48-K. pneumoniae and OXA-48-E. coli clonal diversity (Figure 2, right-hand panel) . Moreover, we observed the emergence of a new epidemic clone VIM-1-ST54-SHV-12-K. pneumoniae (17/22, 77.3%), mainly linked to SWs (14/17). Finally, an outbreak due to NDM-1!CTX-M-15!DHA-1-K. pneumoniae (C-ST101 and H-ST437 clones) was detected (Neurosurgery ward) in the last semester, coinciding with an increased prevalence, but with lower K. pneumoniae clonal diversity (Figure 2 , left-hand panel).
Discussion
The population structure of CPE isolates recovered during the R-GNOSIS project depicted a complex scenario with different carbapenemases disseminated through well-adapted K. pneumoniae clones, but also with sporadic clones of multiple species. Although CPE prevalence remained unchanged over the studied period, increased K. pneumoniae clonal diversity with maintenance of epidemic high-risk clones was observed. Fifty-six percent of CPE colonization was considered to be acquired during the R-GNOSIS project period. Previous admissions to our institution (60.5%) or other healthcare centres (6.8%) were also confirmed.
Consistent with other studies, we described a polyclonal Enterobacteriaceae population harbouring primarily OXA-48 (64.1%) and VIM-1 (26.8%). Other enzymes, such as KPC-3 (3.5%) were sporadically recovered, including NDM-1 (5%) for the first time in our hospital. 13, 14 As expected, K. pneumoniae was predominant (53.5%), but, in contrast to other studies, we found a higher prevalence of E. coli (19.2%) than E. cloacae complex (11.1%), which might reflect efficient penetration of these enzymes as occurred with CTX-Ms. 15, 16 Coinciding with previous data, high coresistance was found, leaving in many cases only colistin, amikacin and tigecycline as therapeutic options. 13, 14 Interestingly, OXA-48 producers (mainly without ESBL) showed lower resistance rates than other CPEs. Characterization of carbapenemase-producing Enterobacteriaceae
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The propensity of bla OXA-48 to spread among different Enterobacteriaceae species has been reported in Spain as mainly linked to ST405-K. pneumoniae and ST11-K. pneumoniae and/or with long-term healthcare facilities. 5, 7, 13, 17 Local epidemiology, including not only carbapenemase but also ESBL producers, could have influenced this situation. Disturbingly, the emergence of OXA-48-E. coli is also described in Spain, even associated with the ST131-E. coli clone, commonly related to CTX-M production. 13, 18, 19 Interestingly, despite the current prevalence of ST131-E. coli among ESBL carriers in Spain (I. Merino, Servicio de Microbiología, Hospital Universitario Ramón y Cajal, Madrid, Spain, personal communication), we did not find this clone carrying carbapenemases.
Differences in colonization rates and clonal diversity in both K. pneumoniae and E. coli were also registered, possibly as a consequence of the circulation and emergence of new clones such as VIM-1-ST54 and NDM-1/ST101. The OXA-48-ST11-K. pneumoniae clone was the most prevalent throughout the study, although it coexisted with a relative abundance of several circulating OXA-48-K. pneumoniae clones, especially during the last period. CC10-OXA-48-E. coli emergence had special epidemiological relevance, since CC10 clones have been associated with CTX-M-15 global dissemination. 20 We suggest that coexistence with persistent highly transmissible clones in healthcare settings, such as ST11-OXA-48-K. pneumoniae, could lead to a casual bla OXA-48 acquisition by other circulating species, through plasmid lateral transmission. The spread of this carbapenemase through well-adapted E. coli clones could be the trigger for the uncontrolled dissemination and establishment of bla OXA-48 in the community, as happened with CTX-M-15. 15 Despite control interventions, the polyclonal dissemination of OXA-48 among different species, including E. coli, along with its particular dispersion within the K. pneumoniae population and its coexistence with other emerging clones, depicts a complex epidemiology in our institution and the need to reinforce these interventions. Hernández-García et al.
